Page last updated: 2024-08-21

aminoimidazole carboxamide and am 251

aminoimidazole carboxamide has been researched along with am 251 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HS; Kwon, J; Lee, ES; Lee, YM; Park, SH; Uhm, KO1
Ferreirós, N; Geisslinger, G; King-Himmelreich, TS; Möser, CV; Niederberger, E; Russe, OQ; Schmetzer, J; Schreiber, Y; Wolters, MC1

Other Studies

2 other study(ies) available for aminoimidazole carboxamide and am 251

ArticleYear
AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway.
    Biochemical and biophysical research communications, 2008, Jun-13, Volume: 370, Issue:4

    Topics: Activating Transcription Factor 3; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Cannabinoids; Cell Line, Tumor; Cell Survival; Humans; JNK Mitogen-Activated Protein Kinases; Multienzyme Complexes; Phosphorylation; Piperidines; Protein Serine-Threonine Kinases; Pyrazoles; Ribonucleotides; Signal Transduction

2008
AMPK contributes to aerobic exercise-induced antinociception downstream of endocannabinoids.
    Neuropharmacology, 2017, Sep-15, Volume: 124

    Topics: Amidohydrolases; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Arachidonic Acids; Cells, Cultured; Endocannabinoids; Female; Male; Mice; Mice, Knockout; Neurons; Nociception; Pain Measurement; Physical Conditioning, Animal; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Ribonucleotides

2017